FDA approves Moderna's mRNA flu vaccine after initially refusing to review it

After refusing to even review it, the FDA has approved Moderna's mRNA seasonal flu vaccine.
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events